Systematically explore the potential hepatotoxic material basis and molecular mechanism of Radix Aconiti Lateralis based on the concept of toxicological evidence chain (TEC)

Kai Zhang,Chuanxin Liu,Tiange Yang,Xinxin Li,Longyin Wei,Dongling Chen,Jiali Zhou,Yihui Yin,Xinyu Yu,Fei Li

DOI: https://doi.org/10.1016/j.ecoenv.2020.111342

IF: 7.129

2020-12-01

Ecotoxicology and Environmental Safety

Abstract:Radix aconiti lateralis (Fuzi) is widely used in China as a traditional Chinese medicine for the treatment of asthenia, pain and inflammation. However, its toxic alkaloids often lead to adverse reactions. Currently, most of the toxicity studies on Fuzi are focused on the heart and nervous system, and more comprehensive toxicity studies are needed. In this study, based on the previous reports of Fuzi hepatotoxicity, serum pharmacochemistry and network toxicology were used to screen the potential toxic components of Heishunpian(HSP), a processed product of Fuzi, and to explore the possible mechanism of HSP-induced hepatotoxicity. The results obtained are expressed based on the toxicological evidence chain (TEC). It was found that 22 potential toxic components screened can affect Th17 cell differentiation, Jak-STAT signaling pathway, glutathione metabolism, and other related pathways by regulating AKT1, IL2, F2, GSR, EGFR and other related targets, which induces oxidative stress, metabolic disorders, cell apoptosis, immune response, and excessive release of inflammatory factors, eventually inducing liver damage in rats. This is the first study on HSP-induced hepatotoxicity based on the TEC concept, providing references for further studies on the toxicity mechanism of Fuzi.

environmental sciences,toxicology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the hepatotoxicity caused by Heishunpian (HSP), a processed product of Radix Aconiti Lateralis (abbreviated as Fuzi). Specifically, the study aims to systematically screen the potential toxic components of HSP through the concept of Toxicological Evidence Chain (TEC) and explore the possible mechanisms of its induction of hepatotoxicity. The research background points out that although Fuzi is widely used in the treatment of weakness, pain and inflammation, the toxic ester - alkaloids it contains often lead to adverse reactions. At present, most of the studies on Fuzi toxicity focus on the heart and nervous system, while relatively few studies on its liver toxicity. Therefore, this study fills this gap in the field and provides a preliminary understanding of the hepatotoxicity mechanisms of Fuzi and its processed product HSP, which is helpful for further safe use and research.